By
Drug Target Review2025-06-02T12:30:48
Researchers at the University of Illinois have achieved the first successful metabolic labelling of platelets, a key step toward using them in targeted drug delivery. The technique could enable short-lived, precision therapies for cancer, immune conditions, and clotting disorders.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-10T09:00:00Z
2026-07-10T06:15:00Z
Contributor Professor Donald E Ingber, By Drug Target Review
2026-07-09T12:00:00Z
2026-07-08T12:00:00Z
2026-07-08T07:58:00Z
Contributor Dr Nick Lynch, By Dr Raminderpal Singh
2025-05-14T14:30:00
Sponsored by Abzena
2026-07-01T13:30:00
Contributor Carrie Maynard and Dr Veronica Fowler
2023-09-06T16:55:04
Sponsored by NanoTemper Technologies
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2024-01-09T09:30:19
Sponsored by Sartorius
Site powered by Webvision Cloud